0001209191-18-058608.txt : 20181114 0001209191-18-058608.hdr.sgml : 20181114 20181114181054 ACCESSION NUMBER: 0001209191-18-058608 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181114 FILED AS OF DATE: 20181114 DATE AS OF CHANGE: 20181114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pedder Simon CENTRAL INDEX KEY: 0001316736 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38112 FILM NUMBER: 181185437 MAIL ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Athenex, Inc. CENTRAL INDEX KEY: 0001300699 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 431985966 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 BUSINESS PHONE: 716-898-8625 MAIL ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20131223 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC DATE OF NAME CHANGE: 20040817 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-11-14 0 0001300699 Athenex, Inc. ATNX 0001316736 Pedder Simon C/O ATHENEX, INC. 1001 MAIN STREET, SUITE 600 BUFFALO NY 14203 0 1 0 0 See Remarks Common Stock 2018-11-14 4 P 0 2908 10.258 A 3908 D Stock Option (Right to Buy) 4.55 2023-05-13 Common Stock 20000 20000 D Stock Option (Right to Buy) 9.00 2026-02-28 Common Stock 100000 100000 D Stock Option (Right to Buy) 11.00 2027-06-13 Common Stock 130000 130000 D This transaction was executed in multiple trades ranging from $10.250 to $10.259. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder full information regarding the number of shares and prices at which the transactions were effected. The option vests in four equal annual installments beginning on May 13, 2014. The option vests in four equal annual installments beginning on February 28, 2017. The option vests in four equal annual installments beginning on June 13, 2018. /s/Teresa Bair, Attorney-in-Fact 2018-11-14